Trials / Completed
CompletedNCT00673660
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Assessment Of Statin Treatment Compliance In Dyslipidemia Patients: An Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 375 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to show the compliance rates of the patients to statin treatment and the reasons of non-compliance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Patient Compliance | Compliance of patients to statin treatment and reasons of compliance or non compliance will be obtained by Patient Reported Outcomes (PROs) every 3 months. |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2008-05-07
- Last updated
- 2021-02-21
- Results posted
- 2010-11-04
Locations
5 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00673660. Inclusion in this directory is not an endorsement.